2 completed. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 2 |
Follow Refsum Disease, Infantile: new trials by email Literature Review of Refsum Disease, Infantile trials Research Report on Refsum Disease, Infantile
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Betaine and Peroxisome Biogenesis Disorders Betaine - Peroxisome Biogenesis Disorders | Phase 3 | Completed | McGill University Health Centre/Research Institute of the McGill University Health Centre | 12 | 2013-03-01 | 2016-06-28 |
| Compassionate Treatment of Patients With Inborn Errors of Bile Acid Metabolism With Cholic Acid Cholic Acids - Infantile Refsum's Disease, Zellweger Syndrome | Phase 3 | Completed | Mirum Pharmaceuticals, Inc. | 85 | 1992-01-01 | 2023-10-03 |
Peroxisomal Disorders (2) · Zellweger Syndrome (2) · Adrenoleukodystrophy (1) · Cholestasis (1) · Peroxisome biogenesis disorders (1)
Abnormalities, Multiple (2) · Brain Diseases (2) · Brain Diseases, Metabolic (2) · Brain Diseases, Metabolic, Inborn (2) · Central Nervous System Diseases (2) · Congenital Abnormalities (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Digestive System Diseases (2) · Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Genetic Diseases, Inborn (2) · Kidney Diseases (2) · Liver Diseases (2) · Male Urogenital Diseases (2) · Metabolic Diseases (2)
Betaine (1) · Cholic Acid (1) · Cholic Acids (1)
McGill University Health Centre/Research Institute of the McGill University Health Centre (1) · Mirum Pharmaceuticals, Inc. (1)
Canada (1) · United States (1)
James Heubi, MD (1) · Kenneth Setchell, PhD (1) · Nancy Braverman, PhD, MD (1)